JournalsHub
.online
Find My Journal
YZ

Yinglan Zhao

Sichuan University CN

ORCID 0000-0002-5168-5842
219
Publications
7,846
Citations
44
H-Index
127
i10-Index
40.11
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China.

X. Gu, Q. Zhang, Y. Chu, Yi-Yang Zhao, Yan-Jun Zhang - Lung Cancer, 2019
Cited by 68 Semantic Scholar

Cost-effectiveness of afatinib and erlotinib as second-line treatments for advanced squamous cell carcinoma of the lung.

Jun Zhu, Wei He, M. Ye, J. Fu, Y. Chu - Future Oncology, 2018
Cited by 22 Semantic Scholar

Research Topics

Cancer, Hypoxia, and Metabolism (25) Metabolomics and Mass Spectrometry Studies (24) Epigenetics and DNA Methylation (20) Synthesis and biological activity (17) Neuroscience and Neuropharmacology Research (13)

Affiliations

National Medical Products Administration
CN 2023 - 2023
Sichuan University
CN 2026 - 2008
West China Medical Center of Sichuan University
CN 2026 - 2017
Southern University of Science and Technology
CN 2017 - 2017
Nagoya City University
JP 2003 - 2003

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now